Textbook giant McGraw Hill sees potential for AI in the classroom—and the risks
Century-old publisher McGraw Hill has a lot of experience bringing technology to education — a playbook it’s turning to for generative AI.
Related Articles
National Telehealth Contingency Staffing Program and VHA Primary Care Quality
This quality improvement study examines the association of individual-level receipt of care from a Clinical Resource Hub clinician with outcomes for Veterans Health Administration (VHA)…
Why OpenAI is Taking So Long to Launch Agents
Imagine you’re asking a computer-using agent from OpenAI, Anthropic or Google to find and order a new outfit for your upcoming holiday party, and in…
‘Forever chemicals’ are polluting water in an unexpected way — via prescription drugs
Researchers found that chemicals, including PFAS, from pharmaceuticals are entering into wastewater — which can be used as drinking water during times of drought.
How Good Are AI ‘Clinicians’ at Medical Conversations?
Researchers design a more realistic test to evaluate AI’s clinical communication skills
This ER doc responds to critical calls in B.C. in his spare time. For free | CBC Radio
Dr. Nicholas Sparrow is doing something different in Canada. He’s responding to critical calls in B.C.’s Kootenay region as a volunteer emergency response physician.
SPRINT Treatment Among Adults With Chronic Kidney Disease
This comparative effectiveness study evaluates whether the beneficial and adverse effects of intensive vs standard blood pressure control observed in the Systolic Blood Pressure Intervention…
Recipe: Jicama Hash With Turkey Bacon and Avocado
Try this lighter version of hash, using jicama and turkey bacon, to start your day.
Journal Editors Sound Alarm on Predatory Medical Journals
These journals take advantage of the current academic environment with its pressure to publish
Pertussis Cases Surging in the United States
MONDAY, Jan. 6, 2025 (HealthDay News) — Rates of pertussis in the United States are surging, with more than 32,000 cases reported as of mid-December…
Pfizer executives descend on Donald Trump’s Mar-a-Lago for planning meeting
Drugmaker is latest titan of corporate America to curry favour with president-elect
